We have managed to build a truly robust and enduring business
In Conversation
Taiwan’s role in the region will be to establish a highly regulated, safe usage of stem cell therapies which will make us the leader in this…
Highly specialized care can be extremely expensive. We simply cannot afford to spread highly specialized care across regions and hospitals
For the last 20 years, we have invested heavily in academic research including genomics, oncology, immunology, neurology, biophotonics, and medical engineering
Overall, I am quite positive – as there are many reasons why companies should choose to expand development and manufacturing operations to Puerto Rico
We were hoping to act as a role model for Taiwan and show that despite being a small country with a small market and limited market…
In Sweden, we have seen incredible investment into the work stations and laboratories in hospitals where we can work to the highest of standards and improve…
My main priority is to grow Magicpharma’s business while developing people – our main asset
Being efficient and gaining knowledge and experience in [rare diseases and highly specialized care] requires higher volumes of patients, which can be difficult in a small…
Taiwan will enjoy a very promising future if the government can support the industry by putting the necessary regulations into place
The best biotech companies and most successful are those who know exactly what is happening on the ground in their therapeutic area now, whilst in parallel…
The sector is moving towards outcome- and value-based healthcare, of which diagnostics will have a big part to play
